The same miR-210 and a set of other angiogenic miRNAs are enriched in SEVs released by metastatic BC cells, a secretory process regulated by neutral sphingomyelinase 2 (nSMase2, SMPD2). The gene discussed is SMPD3; the disease is breast cancer.